Neurology trial tests low-dose lithium for MCI and Alzheimer risk; results miss primary end points but hint at slower verbal memory decline.
Amjad Shono, PA-C
Advertisement
Articles by Amjad Shono, PA-C
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis on the Rise in the United States, Exceeding 450 Cases
2
Same-Day COVID-19 and Flu Vaccination Does Not Raise Adverse Event Risk, Large VA Study Finds
3
Kidney Disease Rates Hold Steady for a Decade as Diabetes-Driven Cases Climb
4
Reducing Recurrence in C Difficile Infection
5